1629 studies found for:    (uterine OR endometrial) AND cancer
Show Display Options
Download search resultsDownload the search results for:
(uterine OR endometrial) AND cancer (1629 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Active, not recruiting Estrogen, Diet, Genetics and Endometrial Cancer
Conditions: Cancer;   Endometrial Cancer;   Ovarian Cancer;   Corpus Uteri;   Endometrium
Intervention: Behavioral: Questionnaire
2 Unknown  Early Detection of Cancers in Low Resource Countries
Conditions: Breast Neoplasms;   Uterine Cervical Neoplasms;   Ovarian Neoplasms;   Endometrial Neoplasms
Interventions: Procedure: Breast Cancer Screening and Diagnosis;   Procedure: Cervical Cancer Screening and Diagnosis;   Procedure: Ovarian Cancer Screening and Diagnosis;   Procedure: Endometrial Cancer Screening and Diagnosis
3 Active, not recruiting Physical Activity After Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Behavioral: Personalized Exercise Program;   Behavioral: Questionnaire;   Behavioral: Suggested Exercise Program
4 Recruiting Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Conditions: Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer;   Sarcoma;   Uterine Leiomyomata;   Vaginal Cancer;   Vulvar Cancer
Interventions: Other: laboratory biomarker analysis;   Other: screening questionnaire administration;   Procedure: study of high risk factors
5 Recruiting Molecular Markers in Treatment in Endometrial Cancer
Conditions: Endometrial Neoplasms;   Neoplasm Metastasis
Intervention: Procedure: Tumor biopsy study
6 Completed Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas
Condition: Endometrial Cancer
Intervention: Behavioral: Questionnaire
7 Active, not recruiting Risk Factors for Endometrial Cancer in Black Women
Condition: Endometrial Cancer
Interventions: Other: questionnaire administration;   Other: study of socioeconomic and demographic variables;   Procedure: evaluation of cancer risk factors
8 Active, not recruiting
Has Results
Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
Conditions: Cervical Cancer;   Endometrial Cancer
Interventions: Drug: cisplatin;   Radiation: intensity-modulated radiation therapy
9 Active, not recruiting Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
Conditions: Endometrial Clear Cell Adenocarcinoma;   Endometrial Serous Adenocarcinoma;   Stage IA Uterine Corpus Cancer;   Stage IB Uterine Corpus Cancer;   Stage II Uterine Corpus Cancer;   Stage IIIA Uterine Corpus Cancer;   Stage IIIB Uterine Corpus Cancer;   Stage IIIC Uterine Corpus Cancer;   Stage IVA Uterine Corpus Cancer
Interventions: Drug: Cisplatin;   Radiation: Radiation Therapy;   Radiation: Internal Radiation Therapy;   Drug: Paclitaxel;   Drug: Carboplatin;   Other: Quality-of-Life Assessment
10 Completed
Has Results
Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers
Conditions: Breast Cancer;   Ovarian Cancer;   Endometrial Cancer;   Cervical Cancer
Intervention: Drug: 852A
11 Active, not recruiting Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
Conditions: Adult Hepatocellular Carcinoma;   Advanced Adult Hepatocellular Carcinoma;   Endometrial Serous Adenocarcinoma;   Localized Non-Resectable Adult Liver Carcinoma;   Lung Carcinoid Tumor;   Malignant Ovarian Mixed Epithelial Tumor;   Malignant Pancreatic Gastrinoma;   Malignant Pancreatic Glucagonoma;   Malignant Pancreatic Insulinoma;   Malignant Pancreatic Somatostatinoma;   Metastatic Digestive System Neuroendocrine Tumor G1;   Ovarian Carcinosarcoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Serous Surface Papillary Adenocarcinoma;   Pancreatic Alpha Cell Adenoma;   Pancreatic Beta Cell Adenoma;   Pancreatic Delta Cell Adenoma;   Pancreatic G-Cell Adenoma;   Pancreatic Polypeptide Tumor;   Recurrent Adult Liver Carcinoma;   Recurrent Digestive System Neuroendocrine Tumor G1;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Pancreatic Neuroendocrine Carcinoma;   Recurrent Primary Peritoneal Carcinoma;   Recurrent Uterine Corpus Carcinoma;   Regional Digestive System Neuroendocrine Tumor G1;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIA Primary Peritoneal Cancer;   Stage IIIA Uterine Corpus Cancer;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIB Primary Peritoneal Cancer;   Stage IIIB Uterine Corpus Cancer;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Cancer;   Stage IIIC Primary Peritoneal Cancer;   Stage IIIC Uterine Corpus Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Cancer;   Stage IV Primary Peritoneal Cancer;   Stage IVA Uterine Corpus Cancer;   Stage IVB Uterine Corpus Cancer;   Uterine Carcinosarcoma
Interventions: Biological: Bevacizumab;   Drug: Temsirolimus
12 Completed Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
Conditions: Endometrial Clear Cell Adenocarcinoma;   Endometrial Serous Adenocarcinoma;   Stage III Uterine Corpus Cancer;   Stage IV Uterine Corpus Cancer
Interventions: Drug: Paclitaxel;   Drug: Cisplatin;   Radiation: Radiation Therapy
13 Terminated Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Conditions: Uterine Cervical Cancer;   Endometrial Cancer
Intervention: Drug: Zalypsis ( PM00104)
14 Completed Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers
Conditions: Ovarian Neoplasms;   Uterine Neoplasms
Intervention: Drug: Topotecan and Taxotere
15 Recruiting Assisted Exercise in Obese Endometrial Cancer Patients
Conditions: Stage I Endometrial Adenocarcinoma;   Uterine Cancer;   Obesity
Interventions: Behavioral: Exercise on stationary recumbent exercise cycle;   Behavioral: Health Education;   Behavioral: Questionnaires;   Procedure: Neuroimaging;   Procedure: Genetic and Biomarkers
16 Recruiting Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples
Conditions: Endometrial Cancer;   Gynecological Cancers
Intervention:
17 Unknown  Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
Condition: Endometrial Cancer
Interventions: Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration
18 Active, not recruiting Optimized Magnetic Resonance Brachytherapy (MR BT) in Cervix Cancer
Condition: Cervix Cancer
Intervention: Radiation: optimised magnetic resonance image-guided intra-uterine brachytherapy
19 Active, not recruiting Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Conditions: Lymphedema;   Stage IA Cervical Cancer;   Stage IA Uterine Corpus Cancer;   Stage IA Vulvar Cancer;   Stage IB Cervical Cancer;   Stage IB Uterine Corpus Cancer;   Stage IB Vulvar Cancer;   Stage II Uterine Corpus Cancer;   Stage II Vulvar Cancer;   Stage IIA Cervical Cancer;   Stage IIIA Vulvar Cancer;   Stage IIIB Vulvar Cancer;   Stage IIIC Vulvar Cancer;   Stage IVB Vulvar Cancer
Interventions: Procedure: Therapeutic Lymphadenectomy;   Procedure: Therapeutic Conventional Surgery;   Procedure: Therapeutic Laparoscopic Surgery;   Procedure: Study of High Risk Factors;   Other: Questionnaire Administration;   Other: Quality-of-Life Assessment
20 Completed A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer
Intervention: Drug: MKC-1

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years